Evidence map›Paper›PMID 35780210›Full record

ArticleBreast cancer research and treatment2022

Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations.

Ashley M Geczik, Jennifer S Ferris, Mary Beth Terry, Irene L Andrulis, Saundra S Buys, Mary B Daly, John L Hopper, Esther M John, Allison W Kurian, Melissa C Southey and 2 more

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Ashley M Geczik *Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY, 10019, USA.
Jennifer S Ferris *Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY, 10019, USA.
Mary Beth TerryDepartment of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY, 10019, USA.
Irene L AndrulisLunenfeld-Tanenbaum Research Institute, Sinai Health System, 600 University Ave, Toronto, ON, M5G 1X5, Canada.
Saundra S BuysDepartment of Medicine and Huntsman Cancer Institute, University of Utah Health, 2000 Circle of Hope Dr, Salt Lake City, UT, 84112, USA.
Mary B DalyDepartment of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA.
John L HopperCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Parkville, VIC, 3010, Australia.
Esther M JohnDepartment of Epidemiology & Population Health, Stanford University School of Medicine, 3145 Porter Drive, Suite E223, Palo Alto, CA, 94304, USA.
Allison W KurianDepartment of Epidemiology & Population Health, Stanford University School of Medicine, 3145 Porter Drive, Suite E223, Palo Alto, CA, 94304, USA.
Melissa C SoutheyCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Parkville, VIC, 3010, Australia.
Yuyan LiaoDepartment of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY, 10019, USA.
Jeanine M GenkingerDepartment of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY, 10019, USA. jg3081@columbia.edu.ORCID http://orcid.org/0000-0002-8438-0412
Columbia University · USColumbia University Irving Medical Center · USStanford Medicine · USThe University of Melbourne · AUFox Chase Cancer Center · USUniversity of Toronto · CAUniversity of Utah · US

Funding

Core-001U01CA164920 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Irene Andrulis, Sarah Violet Colonna · 2018 to 2026
$17.0M
Institutional Career Development CoreKL2TR001874 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GENKINGER, JEANINE M., SHIMBO, DAICHI · 2016 to 2025
$13.6M
NRSA Training CoreTL1TR001875 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPANN, MARISA N, TAYLOR, JACQUELYN Y · 2016 to 2025
$8.9M
NCATS NIH HHS KL2 TR001874NCATS NIH HHS TL1 TR001875NCI NIH HHS TL1TR001875NCI NIH HHS U01 CA164920
6 · The paper itself

Abstract

purposeThe American Cancer Society (ACS) published an updated Guideline for Cancer Prevention (ACS Guideline) in 2020. Research suggests that adherence to the 2012 ACS Guideline might lower breast cancer risk, but there is limited evidence that this applies to women at increased familial and genetic risk of breast cancer.

methodsUsing the Breast Cancer Family Registry (BCFR), a cohort enriched for increased familial and genetic risk of breast cancer, we examined adherence to three 2020 ACS Guideline recommendations (weight management (body mass index), physical activity, and alcohol consumption) with breast cancer risk in 9615 women. We used Cox proportional hazard regression modeling to calculate hazard ratios (HRs) and 95% confidence intervals (CI) overall and stratified by BRCA1 and BRCA2 pathogenic variant status, family history of breast cancer, menopausal status, and estrogen receptor-positive (ER +) breast cancer.

resultsWe observed 618 incident invasive or in situ breast cancers over a median 12.9 years. Compared with being adherent to none (n = 55 cancers), being adherent to any ACS recommendation (n = 563 cancers) was associated with a 27% lower breast cancer risk (HR = 0.73, 95% CI: 0.55-0.97). This was evident for women with a first-degree family history of breast cancer (HR = 0.68, 95% CI: 0.50-0.93), women without BRCA1 or BRCA2 pathogenic variants (HR = 0.71, 95% CI: 0.53-0.95), postmenopausal women (HR = 0.63, 95% CI: 0.44-0.89), and for risk of ER+ breast cancer (HR = 0.63, 95% CI: 0.40-0.98). DISCUSSION: Adherence to the 2020 ACS Guideline recommendations for BMI, physical activity, and alcohol consumption could reduce breast cancer risk for postmenopausal women and women at increased familial risk.

Indexed as

Breast NeoplasmsAlcohol DrinkingAmerican Cancer SocietyExerciseFemaleHumansRegistriesRisk FactorsUnited StatesBreast CancerCancer PreventionIncidenceLifestyle behaviors

Identifiers

PMID35780210
PMCPMC9600083
OpenAlexW4283787414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.